{"id":10170,"date":"2021-06-03T15:04:48","date_gmt":"2021-06-03T22:04:48","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=10170"},"modified":"2021-06-04T15:05:32","modified_gmt":"2021-06-04T22:05:32","slug":"effect-of-bamlanivimab-vs-placebo-on-incidence-of-covid-19-among-residents-and-staff-of-skilled-nursing-and-assisted-living-facilities","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/06\/03\/effect-of-bamlanivimab-vs-placebo-on-incidence-of-covid-19-among-residents-and-staff-of-skilled-nursing-and-assisted-living-facilities\/","title":{"rendered":"Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Preventive treatment with the monoclonal antibody bamlanivimab reduced the risk of COVID-19 among residents and staff of skilled nursing facilities (n=966) who were negative for SARS-CoV-2 infection and seronegative at baseline in a randomized trial (8.5% vs 15.2%, OR=0.43 95% CI 0.28-0.68). All 5 deaths occurred in residents randomized to receive placebo. Participants were enrolled from 74 skilled nursing and assisted living facilities in the US and received the treatment (bamlanivimab or a placebo infusion) within 7 days of a confirmed SARS-CoV-2 case at their facility. They were followed for 24 weeks with 8 additional tests for SARS-CoV-2 infection by RT-PCR.\u00a0 Adverse events were balanced between the bamlanivimab and placebo groups.<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Cohen et al. (June 3, 2021). Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities. JAMA. <\/span><\/i><a href=\"https:\/\/doi.org\/10.1001\/jama.2021.8828\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1001\/jama.2021.8828<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Preventive treatment with the monoclonal antibody bamlanivimab reduced the risk of COVID-19 among residents and staff of skilled nursing facilities (n=966) who were negative for SARS-CoV-2 infection and seronegative at baseline in a randomized trial (8.5% vs 15.2%, OR=0.43 95% CI 0.28-0.68). All 5 deaths occurred in residents randomized to receive placebo. Participants were enrolled&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/06\/03\/effect-of-bamlanivimab-vs-placebo-on-incidence-of-covid-19-among-residents-and-staff-of-skilled-nursing-and-assisted-living-facilities\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-10170","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=10170"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10170\/revisions"}],"predecessor-version":[{"id":10171,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10170\/revisions\/10171"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=10170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=10170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=10170"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=10170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}